{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:43:16Z","timestamp":1780440196218,"version":"3.54.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.sapharm.2020.05.011","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:15:12Z","timestamp":1589361312000},"page":"1950-1953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists"],"prefix":"10.1016","volume":"17","author":[{"given":"Dalia","family":"Dawoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2020.05.011_bib1","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.sapharm.2020.05.011_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int J Surg Lond Engl"},{"issue":"4","key":"10.1016\/j.sapharm.2020.05.011_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jiph.2020.02.033","article-title":"The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat","volume":"13","author":"Arshad Ali","year":"2020","journal-title":"J Infect Publ Health"},{"key":"10.1016\/j.sapharm.2020.05.011_bib4","author":"White House"},{"key":"10.1016\/j.sapharm.2020.05.011_bib6","author":"Roberts"},{"key":"10.1016\/j.sapharm.2020.05.011_bib7","series-title":"Variation in Government Responses to COVID-19","author":"Petherick","year":"2020"},{"issue":"1","key":"10.1016\/j.sapharm.2020.05.011_bib8","first-page":"1","article-title":"Community mitigation guidelines to prevent pandemic influenza \u2014 United States, 2017","volume":"66","author":"Qualls","year":"2017","journal-title":"Morb Mortal Wkly Rep MMWR"},{"issue":"4","key":"10.1016\/j.sapharm.2020.05.011_bib9","first-page":"CD013574","article-title":"Quarantine alone or in combination with other public health measures to control","volume":"4","author":"Nussbaumer-Streit","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.sapharm.2020.05.011_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.sapharm.2020.05.011_bib11","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.sapharm.2020.05.011_bib12","author":"Gopinath"},{"key":"10.1016\/j.sapharm.2020.05.011_bib13","doi-asserted-by":"crossref","unstructured":"Webb L. Covid-19 lockdown: a perfect storm for older people's mental health. J Psychiatr Ment Health Nurs. Published online April 30, 2020. doi:10.1111\/jpm.12644.","DOI":"10.1111\/jpm.12644"},{"key":"10.1016\/j.sapharm.2020.05.011_bib14","doi-asserted-by":"crossref","unstructured":"Stedman M, Davies M, Lunt M, Verma A, Anderson SG, Heald AH. A phased approach to unlocking during the COVID-19 pandemic - lessons from trend analysis. Int J Clin Pract. Published online May 7, 2020:e13528. doi:10.1111\/ijcp.13528.","DOI":"10.1101\/2020.04.20.20072264"},{"key":"10.1016\/j.sapharm.2020.05.011_bib15","doi-asserted-by":"crossref","unstructured":"Petersen E, Wasserman S, Lee S-S, et al. COVID-19-We urgently need to start developing an exit strategy. Int J Infect Dis. Published online April 28, 2020. doi:10.1016\/j.ijid.2020.04.035.","DOI":"10.1016\/j.ijid.2020.04.035"},{"issue":"2","key":"10.1016\/j.sapharm.2020.05.011_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00722-20","article-title":"Report from the American society for microbiology COVID-19 international summit, 23 March 2020: value of diagnostic testing for SARS-CoV-2\/COVID-19","volume":"11","author":"Patel","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.sapharm.2020.05.011_bib17","doi-asserted-by":"crossref","unstructured":"Peto J, Alwan NA, Godfrey KM, et al. Universal weekly testing as the UK COVID-19 lockdown exit strategy. Lancet Lond Engl. Published online April 2020. doi:10.1016\/S0140-6736(20)30936-3.","DOI":"10.1016\/S0140-6736(20)30936-3"},{"key":"10.1016\/j.sapharm.2020.05.011_bib18","doi-asserted-by":"crossref","first-page":"w20225","DOI":"10.4414\/smw.2020.20225","article-title":"COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation","volume":"150","author":"Salath\u00e9","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.sapharm.2020.05.011_bib19","author":"Kim"},{"key":"10.1016\/j.sapharm.2020.05.011_bib20","doi-asserted-by":"crossref","unstructured":"de Wolff T, Pfl\u00fcger D, Rehme M, Heuer J, Bittner M-I. Evaluation of Pool-Based Testing Approaches to Enable Population-wide Screening for COVID-19. ArXiv Prepr ArXiv200411851. Published online 2020.","DOI":"10.1371\/journal.pone.0243692"},{"issue":"3","key":"10.1016\/j.sapharm.2020.05.011_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/mi11030306","article-title":"Novel coronavirus disease (COVID-19): paving the road for rapid detection and point-of-care diagnostics","volume":"11","author":"Nguyen","year":"2019","journal-title":"Micromachines"},{"key":"10.1016\/j.sapharm.2020.05.011_bib23","author":"Coronavirus"},{"key":"10.1016\/j.sapharm.2020.05.011_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.sapharm.2020.05.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31034-5","article-title":"COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges","author":"Phelan","year":"2020","journal-title":"Lancet"},{"issue":"10230","key":"10.1016\/j.sapharm.2020.05.011_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","article-title":"Developing antibody tests for SARS-CoV-2","volume":"395","author":"Petherick","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2020.05.011_bib27","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.sapharm.2020.05.011_bib28","author":"Roche\u2019s"},{"key":"10.1016\/j.sapharm.2020.05.011_bib29","author":"The Association of the British Pharmaceutical Industry (ABPI)"},{"key":"10.1016\/j.sapharm.2020.05.011_bib30","author":"Huang"},{"key":"10.1016\/j.sapharm.2020.05.011_bib31","author":"The Telegraph"},{"issue":"4","key":"10.1016\/j.sapharm.2020.05.011_bib32","doi-asserted-by":"crossref","DOI":"10.2196\/18936","article-title":"Peer-to-Peer contact tracing: development of a privacy-preserving smartphone app","volume":"8","author":"Yasaka","year":"2020","journal-title":"JMIR MHealth UHealth"},{"key":"10.1016\/j.sapharm.2020.05.011_bib33","unstructured":"Barbieri C, Darnis J-P. Technology: An exit strategy for COVID-19? Comment ist aff internazionali comment March. Published online 2020:1\u20134."},{"issue":"2","key":"10.1016\/j.sapharm.2020.05.011_bib34","article-title":"Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action","volume":"6","author":"Ohannessian","year":"2020","journal-title":"JMIR Publ Health Surv"},{"key":"10.1016\/j.sapharm.2020.05.011_bib35","doi-asserted-by":"crossref","unstructured":"Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. Published online March 20, 2020:1357633X20916567. doi:10.1177\/1357633X20916567.","DOI":"10.1177\/1357633X20916567"},{"key":"10.1016\/j.sapharm.2020.05.011_bib36","article-title":"On the frontline against COVID-19: community pharmacists' contribution during a public health crisis","volume":"31","author":"Cadogan","year":"2020","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"10.1016\/j.sapharm.2020.05.011_bib37","article-title":"Scientific and ethical basis for social-distancing interventions against COVID-19","volume":"23","author":"Lewnard","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.sapharm.2020.05.011_bib38","article-title":"Social distancing and the use of PPE by community pharmacy personnel: does evidence support these measures?","author":"Hasan","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2020.05.011_bib39","doi-asserted-by":"crossref","first-page":"m1435","DOI":"10.1136\/bmj.m1435","article-title":"Face masks for the public during the covid-19 crisis","volume":"369","author":"Greenhalgh","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2020.05.011_bib40","doi-asserted-by":"crossref","first-page":"m1442","DOI":"10.1136\/bmj.m1442","article-title":"Covid-19: should the public wear face masks?","volume":"369","author":"Javid","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2020.05.011_bib41","series-title":"Advice on the Use of Masks in the Context of COVID-19","author":"World Health Organisation (WHO)","year":"2020"},{"key":"10.1016\/j.sapharm.2020.05.011_bib42","series-title":"Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages","author":"World Health Organisation (WHO)","year":"2020"},{"issue":"10228","key":"10.1016\/j.sapharm.2020.05.011_bib43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(20)30520-1","article-title":"Mass masking in the COVID-19 epidemic: people need guidance","volume":"395","author":"Leung","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.sapharm.2020.05.011_bib44","doi-asserted-by":"crossref","first-page":"138532","DOI":"10.1016\/j.scitotenv.2020.138532","article-title":"Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - case study from the Republic of Ireland","volume":"725","author":"Rowan","year":"2020","journal-title":"Sci Total Environ"},{"issue":"4","key":"10.1016\/j.sapharm.2020.05.011_bib45","first-page":"183","article-title":"CoViD-19 and PPE: some of us will die because of the shortage","volume":"111","author":"Mandrola","year":"2020","journal-title":"Recenti Prog Med"},{"issue":"5","key":"10.1016\/j.sapharm.2020.05.011_bib46","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00417-020-04641-8","article-title":"Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong","volume":"258","author":"Lai","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"10.1016\/j.sapharm.2020.05.011_bib47","article-title":"Pharmacy staff should wear masks if they cannot keep two metres away from colleagues, new guidance says","author":"Graham","year":"2020","journal-title":"Pharm J"},{"key":"10.1016\/j.sapharm.2020.05.011_bib48","series-title":"Draft Landscape of COVID 19 Candidate Vaccines","author":"World Health Organisation (WHO)","year":"2020"},{"key":"10.1016\/j.sapharm.2020.05.011_bib49","author":"World Health Organisation (WHO)"},{"key":"10.1016\/j.sapharm.2020.05.011_bib50","doi-asserted-by":"crossref","unstructured":"Senanayake SL. Drug repurposing strategies for COVID-19. Future drug discov. Published online March 25, 2020. doi:10.4155\/fdd-2020-0010.","DOI":"10.4155\/fdd-2020-0010"},{"key":"10.1016\/j.sapharm.2020.05.011_bib51","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. doi:10.1016\/S0140-6736(20)31022-9.","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"10.1016\/j.sapharm.2020.05.011_bib53","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.sapharm.2020.05.011_bib54","author":"Food and Drug Administration (FDA)"},{"issue":"4","key":"10.1016\/j.sapharm.2020.05.011_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.sapharm.2019.06.016","article-title":"Community pharmacists at the heart of public health: a longitudinal evaluation of the community pharmacy influenza vaccination service","volume":"16","author":"Deslandes","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2020.05.011_bib58","article-title":"Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond","author":"Aruru","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"10229","key":"10.1016\/j.sapharm.2020.05.011_bib59","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(20)30667-X","article-title":"Evidence informing the UK's COVID-19 public health response must be transparent","volume":"395","author":"Alwan","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"7803","key":"10.1016\/j.sapharm.2020.05.011_bib60","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/d41586-020-00920-w","article-title":"Blocking information on COVID-19 can fuel the spread of misinformation","volume":"580","author":"Larson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.sapharm.2020.05.011_bib61","doi-asserted-by":"crossref","unstructured":"Erku DA, Belachew SA, Abrha S, et al. When fear and misinformation go viral: pharmacists' role in deterring medication misinformation during the \u201cinfodemic\u201d surrounding COVID-19. Res Soc Adm Pharm. Published online May 1, 2020. doi:10.1016\/j.sapharm.2020.04.032.","DOI":"10.1016\/j.sapharm.2020.04.032"},{"key":"10.1016\/j.sapharm.2020.05.011_bib62","doi-asserted-by":"crossref","unstructured":"Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: on the frontline of health service against COVID-19 in LMICs. Res Soc Adm Pharm. Published online April 17, 2020. doi:10.1016\/j.sapharm.2020.04.013.","DOI":"10.1016\/j.sapharm.2020.04.017"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741120305313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741120305313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:21:02Z","timestamp":1761556862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741120305313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1551741120305313"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.05.011","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2020.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}